4-(4-Bromophenyl)Piperidin-4-Ol

4-(4-Bromophenyl)piperidin-4-ol is primarily studied for its potential therapeutic applications, particularly in treating neurodegenerative diseases due to its ability to inhibit key enzymes involved in neurotransmitter degradation. Its unique structure allows it to interact selectively with biological targets, making it valuable in drug development.

The primary biological targets of 4-(4-Bromophenyl)piperidin-4-ol are acetylcholinesterase and monoamine oxidase-B. The compound functions as an inhibitor for both enzymes, preventing the breakdown of neurotransmitters such as acetylcholine and dopamine. This inhibition enhances cholinergic neurotransmission, which is particularly relevant in neurodegenerative conditions like Alzheimer’s disease.

The compound binds to the active sites of acetylcholinesterase and monoamine oxidase-B, forming stable complexes that inhibit their enzymatic activity. This leads to increased levels of neurotransmitters in the brain, promoting enhanced signaling pathways associated with cholinergic and monoaminergic transmission.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.